EUVIMEDEUVIMED entdecken
Open Access

Renal Tubule–Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes

Wen-Xia Yang, Ke Su, Min-Chun Liao, Jing Zhou, Junzheng Peng, Marie-Josée Hébert, Daniel N Leal, Michifumi Yamashita, Kana N Miyata, Janos G Filep, Julie R Ingelfinger, Shao-Ling Zhang iD und 1 weitere

Diabetes · 2025

DOI: 10.2337/db24-0553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Wen-Xia Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM) and Département de Médecine, Université de Montréal, Montréal, Quebec, C…. Hauptthemen laut MEDLINE: Angiotensinogen, Diabetic Nephropathies, Diabetes Mellitus, Type 1, Sodium-Glucose Transporter 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kidney Foundation of Canada, Institute of Nutrition, Metabolism and Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of the intrarenal renin-angiotensin system (iRAS) in diabetic kidney disease (DKD) progression remains unclear. In this study, we generated mice with renal tubule (RT)-specific deletion of angiotensinogen (Agt; RT-Agt−/−) in both Akita and a streptozotocin (STZ)-induced mouse model of diabetes. Both Akita RT-Agt−/− and STZ-RT-Agt−/− mice exhibited significant attenuation of glomerular hyperfiltration, urinary albumin–to–creatinine ratio, glomerulomegaly, and tubular injury. Urinary Agt, angiotensin II (Ang II), and oxidative stress were decreased in Akita RT-Agt−/− mice compared with Akita mice. Moreover, thickened glomerular basement membranes, podocyte foot process effacement, and podocyte loss were ameliorated in Akita RT-Agt−/− mice compared with Akita mice. Mechanistically, intravital microscopy revealed that attenuation of glomerular hyperfiltration in Akita RT-Agt−/− mice was mediated via efferent arteriole vasodilation and afferent arteriole (AA) vasoconstriction. The AA vasoconstriction was regulated, at least partially, through tubuloglomerular feedback by downregulation of sodium–glucose cotransporter 2 (SGLT2) expression in renal proximal tubules. The renal protective effect of iRAS inactivation in Akita RT-Agt−/− mice was more evident than in Akita mice treated with RAS blockers. In vitro, Ang II stimulated and losartan and apocynin inhibited SGLT2 expression in immortalized human renal proximal tubular cells. These findings suggest targeting the iRAS may constitute effective treatment of DKD. Article Highlights Renin-angiotensin system (RAS) activation plays an important role in the progression of diabetic kidney disease (DKD). However, systemic RAS blockade alone is insufficient to reverse DKD progression. We hypothesized that intrarenal renin-angiotensin system (iRAS) activation plays a crucial role in the progression of DKD. We sought to elucidate the role of the iRAS in DKD progression. Selective deletion of angiotensinogen in renal tubules ameliorated the pathological features of DKD. Our study indicates that iRAS inactivation may be a potential approach for preventing DKD disease severity and its progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngiotensinogenDiabetic NephropathiesDiabetes Mellitus, Type 1Sodium-Glucose Transporter 2Kidney TubulesDiabetes Mellitus, ExperimentalAnimalsMiceRenin-Angiotensin SystemDisease Models, AnimalMice, KnockoutMale

Substanzen

AngiotensinogenSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM) and Département de Médecine, Université de Montréal, Montréal, Quebec, Canada.
  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
  • Division of Nephrology, Department of Internal Medicine, Saint Louis University, St. Louis, MO.
  • Centre de Recherche, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, Quebec, Canada.
  • Pediatric Nephrology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

ORCID-Profile: Shao-Ling Zhang, John S D Chan

Förderung

  • Kidney Foundation of Canada
  • Institute of Nutrition, Metabolism and Diabetes

Zitieren

APA

Yang, W. X., Su, K., Liao, M. C., Zhou, J., Peng, J., Hébert, M. J., Leal, D. N., Yamashita, M., Miyata, K. N., Filep, J. G., Ingelfinger, J. R., Zhang, S. L., & Chan, J. S. D. (2025). Renal Tubule–Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db24-0553

Vancouver

Yang WX, Su K, Liao MC, Zhou J, Peng J, Hébert MJ, et al. Renal Tubule–Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes. Diabetes. 2025. doi:10.2337/db24-0553

BibTeX
@article{Yang2025,
  author = {Yang, Wen-Xia and Su, Ke and Liao, Min-Chun and Zhou, Jing and Peng, Junzheng and Hébert, Marie-Josée and Leal, Daniel N and Yamashita, Michifumi and Miyata, Kana N and Filep, Janos G and Ingelfinger, Julie R and Zhang, Shao-Ling and Chan, John S D},
  title = {Renal Tubule–Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-0553}
}
Kostenlos starten →